C. Ronald Blankenship - Apr 29, 2022 Form 4 Insider Report for REGENCY CENTERS CORP (REG)

Role
Director
Signature
/s/ Michael B. Kirwan, Attorney-in-Fact for C. Ronald Blankenship
Stock symbol
REG
Transactions as of
Apr 29, 2022
Transactions value $
$0
Form type
4
Date filed
5/3/2022, 04:43 PM
Previous filing
Feb 11, 2022
Next filing
May 9, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REG Common Stock Award +500 +0.58% 86.6K Apr 29, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REG Restricted Stock Grant Award $0 +1.83K +91.55% $0.00 3.83K Apr 29, 2022 Common Stock 1.83K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents director's fees paid in stock pursuant to Regency's Omnibus Incentive Plan.
F2 Shares vest 100% on the first anniversary of the date of grant.